Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,258,713 papers from all fields of science
Search
Sign In
Create Free Account
Carboxyamidotriazole Orotate
Known as:
1,2,3-Carboxyamido-triazole Orotate
, CTO
The orotate salt form of carboxyamidotriazole (CAI), an orally bioavailable small molecule with potential antiangiogenic and antiproliferative…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: Update From the PROGRESS CTO Registry.
P. Tajti
,
D. Karmpaliotis
,
+30 authors
E. Brilakis
JACC: Cardiovascular Interventions
2018
Corpus ID: 24131470
Highly Cited
2017
Highly Cited
2017
Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion…
J. Sapontis
,
Adam C Salisbury
,
+19 authors
J. Grantham
JACC: Cardiovascular Interventions
2017
Corpus ID: 205799923
Highly Cited
2016
Highly Cited
2016
Hybrid approach improves success of chronic total occlusion angioplasty
William Wilson
,
S. Walsh
,
+12 authors
J. Spratt
Heart
2016
Corpus ID: 23476155
Objectives Treatment options for coronary chronic total occlusions (CTO) are limited, with low historical success rates from…
Expand
Review
2013
Review
2013
Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: A meta‐analysis comparing successful versus failed percutaneous intervention for chronic total occlusion
M. F. Khan
,
C. S. Wendel
,
H. Thai
,
M. Movahed
Catheterization and cardiovascular interventions
2013
Corpus ID: 34307519
Chronic total occlusions (CTOs) represent the most complex and challenging coronary lesions for percutaneous coronary…
Expand
Highly Cited
2009
Highly Cited
2009
Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention.
B. Claessen
,
R. J. van der Schaaf
,
+11 authors
J. Henriques
JACC: Cardiovascular Interventions
2009
Corpus ID: 21419127
Highly Cited
2007
Highly Cited
2007
A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
G. G. Kim
,
V. Donnenberg
,
A. Donnenberg
,
W. Gooding
,
T. Whiteside
JIM - Journal of Immunological Methods
2007
Corpus ID: 40238390
Highly Cited
2005
Highly Cited
2005
Collaterals and the recovery of left ventricular function after recanalization of a chronic total coronary occlusion.
G. Werner
,
R. Surber
,
+4 authors
H. Figulla
American Heart Journal
2005
Corpus ID: 24561227
Highly Cited
2001
Highly Cited
2001
Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience.
James A. Suero
,
S. Marso
,
+5 authors
B. Rutherford
Journal of the American College of Cardiology
2001
Corpus ID: 12969672
Review
1992
Review
1992
Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.
Erich Eigenbrodt
,
Manfred Reinacher
,
U. Scheefers-Borchel
,
H. Scheefers
,
Robert R. Friis
Critical reviews in oncogenesis
1992
Corpus ID: 32126946
As a common characteristic of tumor cells, as well as of normal proliferating cells in the G1-phase of cell cycle, one finds…
Expand
Highly Cited
1988
Highly Cited
1988
Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor.
A. Ichinose
,
E. Davie
Proceedings of the National Academy of Sciences…
1988
Corpus ID: 6516871
Factor XIII (plasma transglutaminase, fibrin stabilizing factor) is a glycoprotein that circulates in blood as a tetramer (a2b2…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE